Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Frequently asked questions
What sector does Jiangsu Hengrui Pharma Co Ltd (1276) operate in?
Jiangsu Hengrui Pharma Co Ltd belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Jiangsu Hengrui Pharma Co Ltd (1276) current stock price?
As of the latest data, Jiangsu Hengrui Pharma Co Ltd stock price is HK$44.54, with a previous close of HK$47.14. Jiangsu Hengrui Pharma Co Ltd lost -HK$2.60 in the last trading session, representing a -5.52% loss.
What is Jiangsu Hengrui Pharma Co Ltd (1276) current market capitalization?
Jiangsu Hengrui Pharma Co Ltd market cap is approximately 318.05 billion.
What is Jiangsu Hengrui Pharma Co Ltd (1276) Earnings Per Share (EPS)?
The trailing EPS is HK$1.25, and the forward EPS is HK$1.40.
What is Jiangsu Hengrui Pharma Co Ltd (1276) Price-to-Earnings (P/E) ratio?
Jiangsu Hengrui Pharma Co Ltd current P/E ratio is 35.53, with a forward P/E of 31.72.
What is Jiangsu Hengrui Pharma Co Ltd (1276) EBITDA?
Jiangsu Hengrui Pharma Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.48 billion.
Does Jiangsu Hengrui Pharma Co Ltd (1276) pay dividends?
Yes. Jiangsu Hengrui Pharma Co Ltd pays annual dividends with an annualized yield of 0.51% and an estimated annual payout of HK$0.23 per share.
When is the next ex-dividend date for Jiangsu Hengrui Pharma Co Ltd (1276)?
The next ex-dividend date is scheduled for April 29, 2027.
How did Jiangsu Hengrui Pharma Co Ltd (1276) perform in its most recent earnings report?
In the last report (June 30, 2026), Jiangsu Hengrui Pharma Co Ltd posted an EPS surprise of -22.73% and a revenue surprise of 9.78%.
What is Jiangsu Hengrui Pharma Co Ltd (1276) beta (volatility) score?
Jiangsu Hengrui Pharma Co Ltd has a beta of 0.041, indicating lower volatility than the overall market.
